New research conducted at the stem cell center, DanStem, at the University of Copenhagen shows that insulin is a key determinant of embryonic stem cell potency in mammals. When large amounts of ...
EMERYVILLE, Calif., October 02, 2025--(BUSINESS WIRE)--Slingshot Biosciences ("Slingshot") today announced two additions to its TruCytes™ cell mimic product line designed to accelerate cell therapy ...
MIAMI - Longeveron Inc. (NASDAQ:LGVN) announced today that the China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal ...
Longeveron receives Japanese patent for potency assay methods to assess human mesenchymal stem cells
Longeveron Inc, a clinical stage biotechnology company developing cellular therapy for life-threatening, rare paediatric and chronic aging-related conditions, announced that the Japan Patent Office ...
MIAMI - Longeveron Inc. (NASDAQ:LGVN) announced Thursday that the Japan Patent Office has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs). The ...
Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron · GlobeNewswire Inc. MIAMI, April 08, 2026 (GLOBE NEWSWIRE)-- Longeveron Inc. (NASDAQ: LGVN), a ...
Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived ...
Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral blood, a lung, a heart, amniotic fluid, inner organs, ...
Stem cell transplants have become widely used to treat diseases such as cancer, blood disorders and autoimmune diseases where defective stem cells are the root cause. These transplants utilize donor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results